Agency Forms Undergoing Paperwork Reduction Act Review, 47465-47466 [2014-19120]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 156 / Wednesday, August 13, 2014 / Notices
Although the information requests may
necessitate that industry members
maintain the requested information
provided to the Commission, they
should already have in place the means
to compile and maintain business
records.
Request for comment: You can file a
comment online or on paper. For the
Commission to consider your comment,
we must receive it on or before October
14, 2014. Write ‘‘Tobacco Reports:
Paperwork Comment, FTC File No.
P054507’’ on your comment. Your
comment—including your name and
your state—will be placed on the public
record of this proceeding, including, to
the extent practicable, on the public
Commission Web site, at https://
www.ftc.gov/os/publiccomments.shtm.
As a matter of discretion, the
Commission tries to remove individuals’
home contact information from
comments before placing them on the
Commission Web site.
Because your comment will be made
public, you are solely responsible for
making sure that your comment doesn’t
include any sensitive personal
information, such as anyone’s Social
Security number, date of birth, driver’s
license number or other state
identification number or foreign country
equivalent, passport number, financial
account number, or credit or debit card
number. You are also solely responsible
for making sure that your comment does
not include any sensitive health
information, such as medical records or
other individually identifiable health
information. In addition, do not include
any ‘‘[t]rade secret or any commercial or
financial information which is obtained
from any person and which is privileged
or confidential . . . , ’’ as provided in
Section 6(f) of the FTC Act, 15 U.S.C.
46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). In particular, do not include
competitively sensitive information,
such as costs, sales statistics,
inventories, formulas, patterns, devices,
manufacturing processes, or customer
names. If you want the Commission to
give your comment confidential
treatment, you must file it in paper
form, with a request for confidential
treatment, and you have to follow the
procedure explained in FTC Rule 4.9(c),
16 CFR 4.9(c). Your comment will be
kept confidential only if the FTC
General Counsel grants your request in
accordance with the law and the public
interest.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comments online, or to send them to the
Commission by courier or overnight
VerDate Mar<15>2010
18:15 Aug 12, 2014
Jkt 232001
service. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
tobaccoreportspra, by following the
instructions on the web-based form. If
this Notice appears at https://
www.regulations.gov/#!home, you also
may file a comment through that Web
site.
If you file your comment on paper,
write ‘‘Tobacco Reports: Paperwork
Comment, FTC File No. P054507’’ on
your comment and on the envelope, and
mail or deliver it to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW., Suite CC–
5610 (Annex J), Washington, DC 20580,
or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW.,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before October 14, 2014. You can find
more information, including routine
uses permitted by the Privacy Act, in
the Commission’s privacy policy, at
https://www.ftc.gov/ftc/privacy.htm.
David C. Shonka,
Principal Deputy General Counsel.
[FR Doc. 2014–19090 Filed 8–12–14; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–14–14VP]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
47465
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Community Context Matters Study—
New—National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The daily use of specific antiretroviral
medications by persons without HIV
infection, but at high risk of sexual or
injection exposure to HIV, has been
shown to be a safe and effective HIV
prevention method. The Food and Drug
Administration approved the use of
Truvada® for preexposure prophylaxis
(PrEP) in July 2012 and CDC has issued
clinical practice guidelines for its use.
With approximately 50,000 new HIV
infections each year, increasing rates of
infection for young MSM, and
continuing severe disparities in HIV
infection among African-American men
and women, incorporation of PrEP into
HIV prevention is important. However,
as a new prevention tool in very early
stages of introduction and use, there is
much we need to learn about how to
implement PrEP in a real world setting
and the need to develop and validate
E:\FR\FM\13AUN1.SGM
13AUN1
47466
Federal Register / Vol. 79, No. 156 / Wednesday, August 13, 2014 / Notices
new measurement tools to capture this
information.
CDC is requesting OMB approval to
collect data over a 3-year period that
will be used to (1) assess the utility of
new measures developed or adapted to
collect information related to this new
intervention (PrEP) and (2) evaluate
community contextual factors that may
impact the acceptability and successful
introduction of a new HIV prevention
method. The project will be conducted
in communities in each of four cities
where PrEP has recently become
available through a local community
health center.
Once per year for three years, two
surveys will be conducted: (1) A
community-based survey to be
administered to 40 persons per city
approached in public venues in the
catchment areas of the PrEP clinics, and
(2) a key stakeholder survey to be
administered to 10 community HIV
leaders nominated by PrEP clinic staff
and HIV community-based
organizations in the clinic communities.
Both surveys will collect data on the
demographics of the participants,
knowledge of PrEP, misinformation
about PrEP, and attitudes about it. The
neighborhood survey will also include
questions about basic HIV knowledge,
attitudes, and beliefs as well as
information about sexual and drug use
behaviors that are indications for PrEP
use. For the stakeholder survey,
additional questions will be included
about type of organization where they
work and organizational experience
with PrEP. Surveys will be administered
face-to-face by trained, local
interviewers.
There are no costs to respondents
other than their time. The total annual
hours are 91.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondent
Form name
Neighborhood Survey Street Interview Participant.
Key Stakeholder Participant ...........................
Neighborhood Interview Recruitment Script
and Informed Consent.
Key Stakeholder Telephone Recruitment
Script and Informed consent.
Survey ............................................................
Survey ............................................................
Street Interview Participant .............................
Key Stakeholder Participant ...........................
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–19120 Filed 8–12–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–14–0906]
mstockstill on DSK4VPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
VerDate Mar<15>2010
18:15 Aug 12, 2014
Jkt 232001
Number of
respondents
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
The Green Housing Study (OMB No.
0920–0906, expires 11/30/2014)—
Extension—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
hours per
response
240
1
5/60
60
1
5/60
160
40
1
1
20/60
20/60
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is seeking a three-year
extension of OMB approval for the
Green Housing Study. The information
collected will help scientists better
understand whether green building
design features reduce human exposures
to chemical and biological agents in the
home and/or improve respiratory health
of children with asthma. This study
directly supports CDC’s Healthy People
2020 Healthy Homes’ health protection
goal. This investigation is also
consistent with CDC’s Health Protection
Research Agenda, which calls for
research to identify the major
environmental causes of disease and
disability and related risk factors.
In 2011, CDC funded two study sites
for the Green Housing Study; one
location was in Boston and the other
was in Cincinnati. In these two cities,
renovations sponsored by the
Department of Housing and Urban
Development (HUD) had already been
scheduled. By selecting sites in which
renovations were already scheduled to
occur, CDC can leverage the opportunity
to collect survey and biomarker data
from residents and collect
environmental measurements in homes
in order to evaluate associations
between green housing and health.
Although the first two study sites
have provided insight into how specific
green building practices (e.g., use of low
chemical-emitting paints and carpets)
E:\FR\FM\13AUN1.SGM
13AUN1
]]>Agencies
[Federal Register Volume 79, Number 156 (Wednesday, August 13, 2014)]
[Notices]
[Pages 47465-47466]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19120]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-14-14VP]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Community Context Matters Study--New--National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The daily use of specific antiretroviral medications by persons
without HIV infection, but at high risk of sexual or injection exposure
to HIV, has been shown to be a safe and effective HIV prevention
method. The Food and Drug Administration approved the use of
Truvada[supreg] for preexposure prophylaxis (PrEP) in July 2012 and CDC
has issued clinical practice guidelines for its use. With approximately
50,000 new HIV infections each year, increasing rates of infection for
young MSM, and continuing severe disparities in HIV infection among
African-American men and women, incorporation of PrEP into HIV
prevention is important. However, as a new prevention tool in very
early stages of introduction and use, there is much we need to learn
about how to implement PrEP in a real world setting and the need to
develop and validate
[[Page 47466]]
new measurement tools to capture this information.
CDC is requesting OMB approval to collect data over a 3-year period
that will be used to (1) assess the utility of new measures developed
or adapted to collect information related to this new intervention
(PrEP) and (2) evaluate community contextual factors that may impact
the acceptability and successful introduction of a new HIV prevention
method. The project will be conducted in communities in each of four
cities where PrEP has recently become available through a local
community health center.
Once per year for three years, two surveys will be conducted: (1) A
community-based survey to be administered to 40 persons per city
approached in public venues in the catchment areas of the PrEP clinics,
and (2) a key stakeholder survey to be administered to 10 community HIV
leaders nominated by PrEP clinic staff and HIV community-based
organizations in the clinic communities. Both surveys will collect data
on the demographics of the participants, knowledge of PrEP,
misinformation about PrEP, and attitudes about it. The neighborhood
survey will also include questions about basic HIV knowledge,
attitudes, and beliefs as well as information about sexual and drug use
behaviors that are indications for PrEP use. For the stakeholder
survey, additional questions will be included about type of
organization where they work and organizational experience with PrEP.
Surveys will be administered face-to-face by trained, local
interviewers.
There are no costs to respondents other than their time. The total
annual hours are 91.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
Neighborhood Survey Street Neighborhood Interview 240 1 5/60
Interview Participant. Recruitment Script and
Informed Consent.
Key Stakeholder Participant........ Key Stakeholder Telephone 60 1 5/60
Recruitment Script and
Informed consent.
Street Interview Participant....... Survey..................... 160 1 20/60
Key Stakeholder Participant........ Survey..................... 40 1 20/60
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-19120 Filed 8-12-14; 8:45 am]
BILLING CODE 4163-18-P
